Additional information was received by the Commission contesting the scientific assessment set out in the RAC opinions of 15 March 2019 concerning mancozeb, of 20 September 2019 concerning 4-methylpentan-2-one, and of 20 September 2019 concerning dimethomorph. That information was assessed by the Commission and was not found sufficient to cast doubts on the scientific analysis contained in the RAC opinions.
Recital 4, Regulation (EU) 2021/849
In forcesince 11 Mar 2021cited 1×
Judgment of the General Court (Fifth Chamber) of 29 October 2025. UPL Europe Ltd and Indofil Industries (Netherlands) BV v European CommissiDecision
In addition, as the Commission itself acknowledges and as is stated in recitals 2 and 4 of Delegated Regulation 2021/849, that delegated regulation is based, as regards the classification of mancozeb, solely on the RAC opinion. …
29 Oct 2025 · 62020TJ0742(01)